MX2008000979A - Protein extracted from plants of the genus lupinus or produced in recombinant form, nucleotide sequence encoding it and its usein animal nutrition, as a plant growth promoter and in the fight against pathogenic fungi - Google Patents
Protein extracted from plants of the genus lupinus or produced in recombinant form, nucleotide sequence encoding it and its usein animal nutrition, as a plant growth promoter and in the fight against pathogenic fungiInfo
- Publication number
- MX2008000979A MX2008000979A MXMX/A/2008/000979A MX2008000979A MX2008000979A MX 2008000979 A MX2008000979 A MX 2008000979A MX 2008000979 A MX2008000979 A MX 2008000979A MX 2008000979 A MX2008000979 A MX 2008000979A
- Authority
- MX
- Mexico
- Prior art keywords
- protein
- lupinus
- plants
- plant
- plant growth
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 158
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 158
- 239000007952 growth promoter Substances 0.000 title claims abstract description 20
- 241000219745 Lupinus Species 0.000 title claims description 96
- 241000196324 Embryophyta Species 0.000 title claims description 91
- 230000001717 pathogenic Effects 0.000 title claims description 23
- 241000233866 Fungi Species 0.000 title claims description 20
- 229920001850 Nucleic acid sequence Polymers 0.000 title claims description 9
- 235000019728 animal nutrition Nutrition 0.000 title abstract description 9
- 230000000694 effects Effects 0.000 claims abstract description 32
- 238000002360 preparation method Methods 0.000 claims abstract description 23
- 230000000843 anti-fungal Effects 0.000 claims abstract description 17
- 239000003337 fertilizer Substances 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 230000003261 anti-oomycete Effects 0.000 claims abstract description 6
- 230000018109 developmental process Effects 0.000 claims description 22
- 244000052769 pathogens Species 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 12
- 125000000539 amino acid group Chemical group 0.000 claims description 9
- 241000233654 Oomycetes Species 0.000 claims description 7
- 241000238631 Hexapoda Species 0.000 claims description 6
- 235000016709 nutrition Nutrition 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- 229920003013 deoxyribonucleic acid Polymers 0.000 claims description 5
- 241000588724 Escherichia coli Species 0.000 claims description 4
- 241000607479 Yersinia pestis Species 0.000 claims description 4
- 230000001764 biostimulatory Effects 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 230000035764 nutrition Effects 0.000 claims description 3
- 230000008929 regeneration Effects 0.000 claims description 3
- 238000011069 regeneration method Methods 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 230000001413 cellular Effects 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 102100001249 ALB Human genes 0.000 claims 1
- 101710027066 ALB Proteins 0.000 claims 1
- 229940050528 albumin Drugs 0.000 claims 1
- 159000000007 calcium salts Chemical class 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 159000000003 magnesium salts Chemical class 0.000 claims 1
- 238000011084 recovery Methods 0.000 claims 1
- 230000000855 fungicidal Effects 0.000 abstract description 11
- 239000000417 fungicide Substances 0.000 abstract description 11
- 150000001413 amino acids Chemical class 0.000 abstract description 8
- 230000000749 insecticidal Effects 0.000 abstract description 6
- 239000002917 insecticide Substances 0.000 abstract description 6
- 230000003389 potentiating Effects 0.000 abstract description 5
- 230000002797 proteolythic Effects 0.000 abstract description 5
- 230000036425 denaturation Effects 0.000 abstract description 3
- 238000004925 denaturation Methods 0.000 abstract description 3
- 230000003000 nontoxic Effects 0.000 abstract description 3
- 231100000252 nontoxic Toxicity 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 abstract description 2
- 235000003869 genetically modified organisms (GMOs) Nutrition 0.000 abstract description 2
- 230000004048 modification Effects 0.000 abstract description 2
- 238000006011 modification reaction Methods 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 136
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 238000000034 method Methods 0.000 description 16
- 210000004215 spores Anatomy 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 15
- 241000282412 Homo Species 0.000 description 11
- 230000035784 germination Effects 0.000 description 9
- 235000010469 Glycine max Nutrition 0.000 description 8
- 240000007842 Glycine max Species 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 8
- 239000011575 calcium Substances 0.000 description 8
- 229910052791 calcium Inorganic materials 0.000 description 8
- 241000221785 Erysiphales Species 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 7
- 239000011777 magnesium Substances 0.000 description 7
- 229910052749 magnesium Inorganic materials 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 210000001519 tissues Anatomy 0.000 description 7
- 101700014023 AFP Proteins 0.000 description 6
- 101700077278 ANTF Proteins 0.000 description 6
- 102000009027 Albumins Human genes 0.000 description 6
- 108010088751 Albumins Proteins 0.000 description 6
- 101700033123 IAAT Proteins 0.000 description 6
- 102000006395 Globulins Human genes 0.000 description 5
- 108010044091 Globulins Proteins 0.000 description 5
- 241000220317 Rosa Species 0.000 description 5
- 210000004027 cells Anatomy 0.000 description 5
- 230000000295 complement Effects 0.000 description 5
- 230000000875 corresponding Effects 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 230000002538 fungal Effects 0.000 description 5
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000001131 transforming Effects 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 240000000613 Citrullus lanatus Species 0.000 description 4
- 241000498271 Necator Species 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 229930013930 alkaloids Natural products 0.000 description 4
- 235000013527 bean curd Nutrition 0.000 description 4
- 150000001768 cations Chemical class 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 231100000676 disease causative agent Toxicity 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 230000004763 spore germination Effects 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 108020004999 Messenger RNA Proteins 0.000 description 3
- 241000233626 Plasmopara Species 0.000 description 3
- 102000007312 Recombinant Proteins Human genes 0.000 description 3
- 108010033725 Recombinant Proteins Proteins 0.000 description 3
- 240000006365 Vitis vinifera Species 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000013351 cheese Nutrition 0.000 description 3
- 239000000287 crude extract Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 239000002609 media Substances 0.000 description 3
- 229920002106 messenger RNA Polymers 0.000 description 3
- 230000001376 precipitating Effects 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 2
- 210000002421 Cell Wall Anatomy 0.000 description 2
- 102000012286 Chitinases Human genes 0.000 description 2
- 108010022172 Chitinases Proteins 0.000 description 2
- 229920002676 Complementary DNA Polymers 0.000 description 2
- 241000510928 Erysiphe necator Species 0.000 description 2
- 240000000894 Lupinus albus Species 0.000 description 2
- 235000010649 Lupinus albus Nutrition 0.000 description 2
- 101700014745 PR1B1 Proteins 0.000 description 2
- 241001480007 Phomopsis Species 0.000 description 2
- 210000002966 Serum Anatomy 0.000 description 2
- 241000510929 Uncinula Species 0.000 description 2
- 241000219094 Vitaceae Species 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000001580 bacterial Effects 0.000 description 2
- 230000001851 biosynthetic Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 235000019621 digestibility Nutrition 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N edta Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 230000003899 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- 235000021021 grapes Nutrition 0.000 description 2
- 239000001963 growth media Substances 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 230000001965 increased Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000000813 microbial Effects 0.000 description 2
- 229910001453 nickel ion Inorganic materials 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical Effects 0.000 description 2
- 238000000399 optical microscopy Methods 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 239000001965 potato dextrose agar Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000751 protein extraction Methods 0.000 description 2
- 235000005974 protein supplement Nutrition 0.000 description 2
- 210000001938 protoplasts Anatomy 0.000 description 2
- 230000002829 reduced Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000002194 synthesizing Effects 0.000 description 2
- 230000002588 toxic Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 238000009369 viticulture Methods 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 241000222195 Ascochyta Species 0.000 description 1
- 102000024969 Bacterial Proteins Human genes 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 241001465180 Botrytis Species 0.000 description 1
- 241001157813 Cercospora Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- DJHJJVWPFGHIPH-OODMECLYSA-N Chitin Chemical compound O[C@@H]1C(NC(=O)C)[C@H](O)OC(CO)[C@H]1COC[C@H]1C(NC(C)=O)[C@@H](O)[C@H](COC[C@H]2C([C@@H](O)[C@H](O)C(CO)O2)NC(C)=O)C(CO)O1 DJHJJVWPFGHIPH-OODMECLYSA-N 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 229920001405 Coding region Polymers 0.000 description 1
- 241000222199 Colletotrichum Species 0.000 description 1
- 241000935926 Diplodia Species 0.000 description 1
- 229940022766 EGTA Drugs 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 229940088598 Enzyme Drugs 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000221787 Erysiphe Species 0.000 description 1
- 206010049796 Excoriation Diseases 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 210000001035 Gastrointestinal Tract Anatomy 0.000 description 1
- 210000000987 Immune System Anatomy 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241001495424 Macrophomina Species 0.000 description 1
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L MgCl2 Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 1
- 210000004080 Milk Anatomy 0.000 description 1
- 241001226034 Nectria <echinoderm> Species 0.000 description 1
- 101700071547 OLP Proteins 0.000 description 1
- 101700023898 OLP1 Proteins 0.000 description 1
- 101700086502 OLPA Proteins 0.000 description 1
- 108091005771 Peptidases Proteins 0.000 description 1
- 102000035443 Peptidases Human genes 0.000 description 1
- 241000936613 Peronospora farinosa Species 0.000 description 1
- 241001503951 Phoma Species 0.000 description 1
- 241000233614 Phytophthora Species 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000221300 Puccinia Species 0.000 description 1
- 241000233639 Pythium Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241001361634 Rhizoctonia Species 0.000 description 1
- 101710033092 SP41A Proteins 0.000 description 1
- 102100019308 SPARC Human genes 0.000 description 1
- 108050000251 SPARC Proteins 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- 101700038834 TLP1A Proteins 0.000 description 1
- 101700051075 TULP1 Proteins 0.000 description 1
- 108010076830 Thionins Proteins 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 230000001775 anti-pathogenic Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000035569 catabolism Effects 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000004059 degradation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- 230000000408 embryogenic Effects 0.000 description 1
- 210000002257 embryonic structures Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- -1 glucanases Proteins 0.000 description 1
- 235000009754 grape Nutrition 0.000 description 1
- 235000012333 grape Nutrition 0.000 description 1
- 125000003372 histidine group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000000670 limiting Effects 0.000 description 1
- 108010053156 lipid transfer protein Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000002934 lysing Effects 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- 230000017066 negative regulation of growth Effects 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 210000000056 organs Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 238000002135 phase contrast microscopy Methods 0.000 description 1
- 239000000590 phytopharmaceutical Substances 0.000 description 1
- 229920001690 polydopamine Polymers 0.000 description 1
- 230000001124 posttranscriptional Effects 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000001737 promoting Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000001850 reproductive Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Abstract
This invention is related to the extraction of a protein from the seeds, cotyledons or plantlets ofLupinusgenus, as well as to the way of producing it in recombinant form and of expressing it in genetically modified plants. Due to the exceptional characteristics exhibited by this protein in what concerns:its potent antifungal and anti-Oomycete activity, which confers great potential to the protein as a fungicide, (2) its strong plant growth promoter activity, particularly notorious on unhealthy or naturally weakenedplants, (3) its extreme resistance to denaturation, which allows the use of the protein under field conditions, (4) its great susceptibility to proteolytic attack, which makes it harmless to the environment and nontoxic for man, and (5) its well balanced amino acid composition. It is claimed its use, or of any modification of the protein that maintains its biological properties, as a supplement in human or animal nutrition and as a fungicide, insecticide, growth promoter, fertilizer or in the preparation of genetically modified organisms.
Description
PROTEIN EXTRACTED FROM GENDER PLANTS Lup ± n s O
WHICH IS PRODUCED RECOMBINANTLY, NUCLEOTIDE SEQUENCE THAT CODIFIES FOR THE SAME AND ITS USE IN
ANIMAL NUTRITION, AS A PROMOTER OF VEGETABLE GROWTH AND IN THE FIGHT AGAINST PATHOGENIC FUNGI
FIELD OF THE INVENTION
This invention is included in the area of Biology, with its practical applicability as a fungicide, insecticide, growth promoter or fertilizer belongs to the fields of Agronomic and Agricultural Sciences and due to its applicability as a complement in the diet of animals belongs to the Field of Human and Animal Nutrition.
BACKGROUND OF THE INVENTION
This invention relates to a protein with antifungal, anti-oomycete and plant growth promoter properties, extracted from seeds, cotyledons or seedlings of the genus Lupinus, and its application in the control of pathogens that attack plants and as a bio -stimulant vegetable. This protein can be applied directly to plants, or plants can be
They can genetically modify them to express the protein in their tissues. In addition, due to its inherent unusual characteristics, the protein can be used in the preparation of protein concentrates useful as supplements in the diet of humans and other animals. The present invention also describes the nucleotide DNA sequence corresponding to the gene fragment coding for the Lupinus protein, as well as its sequence of amino acid residues, to microorganisms transformed with the gene fragment encoding the Lupinus protein and methods for its application as a fungicide, insecticide, plant growth promoter or fertilizer or as a complement in human or animal nutrition. Also an object of this invention is the protein characterized by the sequence of amino acid residues referred to above, in which one or more amino acid residues are absent, have been replaced or added, or maintain their biological activity after being subjected to chemical modification , such as, for example, glycosylation. The control of pathogens is a serious problem worldwide with respect to the most important crops. Pathogenic fungi are particularly
important in regard to the storage of agricultural products. Currently, control over fungal growth is usually achieved through massive applications of chemical fungicides. However, the phytopharmaceutical products currently available on the market show several serious disadvantages. On the one hand, they present high economic and environmental costs; On the other hand, many fungal species have developed mechanisms of resistance against some important fungicides, often making them obsolete in a few years after their introduction to the market. Even when plants do not have an immune system that resembles that of animals, they have developed an inherent resistance to the attack of pathogenic fungi. However, the techniques used for cultivation, harvest and vegetable storage in modern agriculture very often promote adequate or optimal conditions for the development of pathogens. In addition, the number of microbial pathogens that can affect and put at risk plant crops is quite high. As an example, reference can be made to the following genera: Al ternaría, Ascochyta, Botrytis, Cercospora, Colletotrichum, Diplodia, Erysiphe, Fusarium, Gaeumanomyces, Macrophomina, Nectria, Phoma, Phomopsis, Phyma totrichum, Phytophthora, Plasmopara, Puccinia,
Pythium, Rhizoctonia, Uncinula, and Verticilliu. The application of fungicides currently available in the market is limited to some of these genera, and is not an effective solution for the control of plant infections. An alternative strategy in the fight against microbial pathogens is the identification and purification of substances of biological origin that have potent anti-fungal activity. The identification of said compounds involves investigating a variety of organisms, such as plants and microorganisms, with respect to substances that are later analyzed in antifungal tests and finally isolated and characterized. In this way, many classes of antifungal proteins have already been isolated, including chitinases, cysteine-rich proteins that bind strongly to chitin, β-1,3-glucanases, permeatins, thionins and proteins for lipid transfer. It is believed that these proteins play a fundamental role in the natural defenses of plants against the attack of pathogens. In the available literature several methodologies are described on the use of antifungal proteins, extracted from plants or microorganisms, either for direct application on pathogens, or on transgenic plants that express
said proteins. The antifungal proteins most frequently used in these methodologies include chitinases, glucanases, osmotin-like proteins and lysozymes. Several studies have shown that genetically modified plants that overexpress these proteins have increased resistance to many pathogens (European Patent No. 0392 225). Modern Molecular Biology techniques allow the development of recombinant DNA technology and, consequently, plant transformation with genes that code for antifungal proteins. This method usually involves the insertion of the gene encoding the protein of interest into a plant tissue, followed by regeneration of a whole plant from the genetically modified plant tissue. However, the activity of some of these proteins is reduced by the presence of ions, in particular potassium, sodium or calcium. For this reason, although proteins may exhibit potent antifungal activity in in vitro tests, they may be ineffective in vivo due to the high physiological concentrations of the ions that are naturally present in the transformed plant tissues. In conclusion, it is imperative to identify and purify novel compounds of
biological origin that have anti-pathogenic properties in the fight against pathogens that affect plants. Particular importance should be given to those compounds that are effective over a broad range of pathogens and that maintain biological activity under in vivo conditions. Agricultural practices have been optimized, over a long period of time, to promote plant growth and development and to increase crop production. On the other hand, it is predictable that, in the medium to long term, there may be a shortage of food in many areas of the planet. Current techniques to control plant growth under environmentally controlled conditions are costly and require complex equipment. For these reasons, many researchers have investigated and reported physiologically active substances, either natural or synthetic, that exhibit an intensifying effect on the growth and development of crops. However, only a few of these substances have found practical application under real agricultural conditions. Therefore, it is also increasingly important to discover or develop plant growth promoters that are not aggressive to the environment and that do not present toxicity to humans, animals and the environment. Leguminous plants or, in a more
specifies, its seeds, are considered as the main source of protein worldwide for the 'nutrition of humans and animals. In this sense, soybeans play a prominent role, not only because of the high protein content and quality of their seeds but also because of their richness in oil. However, from the agricultural point of view, soybeans require fertile soils and an abundant supply of water. The plants that belong to the genus Lupinus have conquered, through the last decades, a relevant position, strong and of great potential in comparison with the soybeans. If, on the one hand, their seeds have levels of protein and oil comparable to those of soybeans, on the other hand, their species are well adapted to poor soils and conditions of low water availability. For these reasons, lupins have sometimes been considered the "poor cousins" of soybeans. The high level of alkaloids that are toxic to animals and that are naturally present in traditional wild-type lupine seeds have long prevented the widespread cultivation of Lupinus species and the use of their seeds for animal and human consumption. . This is the main reason why the lupine crop has lagged behind the
Soy bean cultivation. In Portugal, for example, the traditional consumption of lupine seeds has long been associated with the ingestion of beer. These seeds are first boiled in water (heating to 100 ° C destroys the ability of the seeds to germinate but does not block the imbibition process) and then they are submerged under running water for a few days to remove the toxic alkaloids. However, the recent application of selection techniques allowed the development of the so-called sweet lupine varieties, characterized by containing a low alkaloid content in the seed (<0.004% w / w), as opposed to the more bitter traditional cultivars. (alkaloid content > 0.004% w / w). For this reason, the seeds of sweet lupine varieties can be used safely as food for humans and animals. Therefore, an increasing development of food products derived from lupine is predictable for the nutrition of both humans and animals, as has happened for several decades with soybeans. This is particularly important in the case of lupine seed proteins, either albumins or globulins.
SUMMARY OF THE INVENTION
It is expected that the present invention solves the technical problem associated with the identification and purification of compounds of biological origin that are capable of controlling a wide variety of pathogens that affect plant crops and that act as promoters of plant growth while maintaining their biological activities under in vivo conditions. The solution is based on the discovery and identification by the present invention of a protein present in plants belonging to the genus Lupinus, which exhibits the following unusual characteristics: (i) potent antifungal and anti-oomycete activity, which confers it great potential as a fungicide; (ii) strong activity. as a promoter of plant growth, particularly noticeable in diseased or naturally weakened plants; (iii) extreme resistance to denaturation, which allows its use under field conditions; (iv) a very high susceptibility to proteolysis, which makes it harmless, environmentally friendly and non-toxic to humans and animals; and (v) a well-balanced amino acid composition. Therefore, the first aspect of this
invention relates to the protein defined in claim 1. A second aspect of the present invention relates to a DNA fragment encoding the protein (claim number 3). The invention also relates to the use of the protein, or any preparation that contains it, as a fungicide, insecticide, growth promoter or fertilizer, either by direct application, in recombinant form or by expression in genetically modified organisms. Finally, the invention considers the use of the protein or any preparation that contains it as a complement in human or animal nutrition.
BRIEF DESCRIPTION OF THE FIGURES
Figure 1 - Grape leaves highly infected with powdery mildew are sprinkled with water (leaf on the right) or with the protein extracted from Lupinus (leaf on the left). (A) 24 hours after sprinkling; (B) 2 months after the spraying. Figure 2 - Observations of optical microscopy of the germination of spores from the fungus responsible for powdery mildew in vine. The fungal spores are carefully removed from the surface of infected young vine leaves and inoculated on agar with
0.6% water (w / v). (A), (B) and (C) - Controls; (D) and (E) -addition of 200 μg of the total protein fraction from mature grapes, which contain proteins related to pathogenesis (PR); (F) and (G) - addition of 200 μg of the protein extracted from Lupinus. Each test is observed after 24 and 48 hours. Phase contrast microscopy is used and the magnification used is 125X. Figure 3 - Observations with metallurgical microscope of vine leaves. (A) Healthy leaves; (B) Leaves infected with powdery mildew; (C) Leaves infected with powdery mildew, 12 hours after spraying with the protein extracted from Lupinus. The magnification used is specified in each photograph. Figure 4 - Effect of the protein from
Lupinus, produced in a recombinant form in Escherichia coli, on the germination and development of spores of Uncinula neca tor, the causative agent of powdery mildew. Figure 5 - Rose plants are sprayed in the same stage of development with water (rose plant to the right) or with a solution containing the protein extracted from Lupinus (200 μg of protein / ml; left) . The photograph shows the stage of development of both plants three weeks after the
aspersion. Figure 6 - Watermelon plants produced in a nursery. Six weeks after the start of germination the plants are sprayed with water (control; A), a crude Lupinus extract containing 100 μg of protein / ml (B), a commercially available plant growth promoter (recommended concentration) by the manufacturer) (C), and a crude Lupinus extract containing 200 μg of protein / ml (D). The experiment is followed for two weeks and the plants are photographed. Figure 7 - Typical profile of the insolubility of globulins from plants of the genus Lupinus as a function of calcium and magnesium concentrations. This profile is taken as an example to show the effect of these cations on the self-aggregation of the protein extracted from Lupinus (M) and Lupinus β-conglutin (O). β-Conglutine (0.5 mg * ml_1; O) and protein extracted from Lupinus (0.5 mg-ml-1; M) are purified from dry seeds or from cotyledons detached from seedlings that are germinated and grown for eight days, respectively .
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to a protein
Novelty with powerful antifungal properties, which exhibits a potent activity on the germination and development of spores from fungal and oomycete pathogens for plants, and with activity of plant growth promoter, particularly notable in diseased or naturally weakened plants. The invention also considers the use of the protein or any preparation that contains it as a complement in human or animal nutrition. The DNA nucleotide sequence of the gene fragment encoding the Lupinus protein does not share any significant homology with any other antifungal protein that has been isolated from plants. The Lupinus protein constitutes a novel type of protein between proteins. antifungal agents described in plants. The protein referred to in the present invention is purified from cotyledons extracted from germinated seedlings of the genus Lupinus. The present invention includes the description of the methodology used to isolate the protein from plant tissues, the DNA nucleotide sequence of the gene (A) fragment encoding it, and the corresponding sequence of amino acid residues (B) .
(A) 5 'CGTAGACAAAGGAACCCTTATCACTTCAGCTCTCAAAGATTCCAAACTCT TTACAAAAATAGGAATGGCAAAATCCGTGTG CTCGAGAGGTTTGAC- CAAAGAACCAATAGACTTGAGAATCTCCAAAACTACCGCATTGTTGAGTTC CAATCAAAACCTAACA CTCTCATTCTCCCTAAACACTCTGATGCTGAC- TACGTCCTCGTTGTACTCAATGGTAGAGCCACAATCACGATAGTAAACCC TGATAGAAGACAAGCATATAACCTTGAGTATGGCGATGCTCTCAGAATCCC AGCTGGCTCAACTTCATATATCCTTAACCCG GATGACAACCAGAAGCTTA- GAGTAGTCAAGCTCGCAATACCCATCAACAATCCTGGCTACTTTTATGATT TCTATCCATCGA GTACTAAAGACCAACAATCCTACTTCAGTG- ACAAAGGATTATTTTAGGGAATGAGGAT GCTTCAGCAGGAACACTTTAGAGGCCACCTTCAATACTCGTTATGAAGAGA T 3'
(B) 5 'RRQRNPYHFS SQRFQTLYKN RNGKIRVLER FDQRTNRLEN
LQNYRIVEFQ SKPNTLILPK HSDADYVLVV LNGRA TITIV NPDRRQAYNL EYGDALRIPA GSTSYILNPD DNQKLRVVKL AIPINNPGYF YDFYPSSTKD QQSYFSGFSR NTLEATFNTR YEEIQRIILG NED 3 'This protein seems to occur naturally only during a very short period of time in the life of seedlings of the genus Lupinus. The inventors of the present invention have shown that β-conglutin, the most important seed reserve protein of the genus Lupinus, is the biosynthetic precursor of the Lupinus protein. In effect, the Lupinus protein is a protein
highly processed that has experienced several levels of chemical modification. This greatly increases the difficulty of their study, including the sequence determination of the amino acid residues and the corresponding nucleotides. During the formation of the seed, the gene coding for β-conglutin is transcribed in the corresponding mRNA, whose translation results in the synthesis of the biosynthetic precursor of β-conglutin. This precursor is then extensively processed, including glycosylation, from which the several tens of different types of subunits constituting β-conglutin are produced. In the next cycle of vegetative growth, several days after the onset of germination, the initial steps in the catabolism of β-conglutin involve the proteolytic cleavage of all or most of its constituent subunits, which results in the accumulation of the protein described in this invention. Due to its intrinsic antifungal properties, which are naturally exploited by the host plant, this protein is maintained at very high concentrations in the cotyledons of the developing plants, during a life stage in which the plant is more sensitive to attack by fungi and insects. After a few days, the protein is degraded and its amino acids are used in the growth
of the young plant. The Lupinus protein described in the present invention has some properties that distinguish it from the other antifungal proteins described in the literature. This makes it a promising target with great potential to develop an efficient method to control the fungi that affect plants and / or animals: (1) Powerful antifungal and anti-oomycete activity, which gives great potential to the protein as a fungicide, (2) Strong activity of plant growth promoter, particularly noticeable in diseased or naturally weakened plants, (3) extreme resistance to denaturation, which allows the use of the protein under field conditions, (4) Great susceptibility to proteolytic attack , which makes it harmless to the environment and non-toxic to the human, and (5) A well-balanced amino acid composition. The protein can also be used as an insecticide, growth promoter or fertilizer, and as a food supplement in human or animal nutrition. Two practical problems in today's agriculture
in day they are the reduction or inhibition of growth observed in diseased or naturally weakened plants and the toxicity normally associated with the biostimulants available. The protein extracted from plant tissues of Lupinus exhibits a strong growth promoter activity during the growth and development of the plant. In fact, the Lupinus preparations or extracts containing the protein possess a strong bio-stimulatory activity in all the plants analyzed, including, for example, grapevine, rose, watermelon and tomato. This effect is notorious for protein concentrations equal to or greater than 200 μg / ml. The other components present in non-pure extracts of the Lupinus protein add value to the preparations because they act as a foliar fertilizer. The absence of toxicity of Lupinus protein for humans, animals and the environment indicates that its application in agriculture does not have any harmful effect on the environment. Another aspect of the present invention refers to the methodology used for the recombinant production of Lupinus protein in bacteria, with the aim of expressing it constitutively in genetically modified plants. Eventually, these plants may present a high level of resistance to pathogenic fungi, specifically with respect to fungi that are difficult to control
(as in the case of fungi responsible for the so-called wood diseases), against which traditional fungicides of exogenous application are not fully effective. The protein is extracted from seedlings of
Lupinus albus cv. LeBlanc eight days old. The seeds are placed in a room at constant temperature (25 ° C in the day, 20 ° C at night) with a photoperiod of 16 light hours / 8 dark hours. After harvesting, the cotyledons are frozen in liquid nitrogen. Protein extraction is carried out in buffer solution 100 mM Tris-HCl, pH 7.5, containing 10% (w / v) NaCl, 10 mM EDTA (ethylenediaminetetraacetic acid) and 10 mM EGTA (ethylene glycol bis ( ß-aminoethyl ether) -N, N, N ', N' -tetra-acetic). After an incubation period of 30 minutes at 4 ° C, the extract is centrifuged at 30,000 g, for 1 hour at 4 ° C. The salt of the supernatant is removed and the protein extracted from Lupinus is subsequently purified by FPLC (liquid chromatography of peptide and rapid protein) -anion exchange chromatography. The N-terminal sequence determination of the protein extracted from Lupinus is achieved by Edman degradation. The sequence obtained from amino acid residues is used to design degenerate primers. MRNA
Total is extracted from developing seeds of Lupinus albus at a stage in which the maximum synthesis of the β-conglutin precursor occurs. The extraction of mRNA is carried out using protocols / kits for purification of mRNA from plant material. The cDNA corresponding to the gene fragment coding for the protein extracted from Lupinus is amplified by PCR (polymerase chain reaction) using the previously designed degenerate primers. Using the nucleotide sequence obtained as a template, new primers are designed and the complete nucleotide sequence of the gene fragment coding for the protein extracted from Lupinus is achieved using the RACE 3 'and 5' technique (rapid amplification of the cDNA ends). The Lupinus protein is produced recombinantly in the bacterium Escherichia coli. The gene fragment encoding the Lupinus protein is cloned into an appropriate vector, which allows the association of the gene of interest to the T71ac promoter. This promoter is inductive; therefore, the expression of genes that are associated with it occurs exclusively in the presence of isopropylthio-β-galactoside sugar. Finally, the competent cells of Escherichia coli are transformed. As described above, the protein of
Lupinus is obtained in a recombinant form from bacteria. However, to be analyzed for its antifungal activity, the recombinant Lupinus protein has to be isolated from all other bacterial proteins. For this purpose, the Lupinus protein is previously produced in a recombinant form with a histidine residue tag (His-Mark). The methodology used for its purification is based on the high affinity of nickel ions for the His brand. In this way, having nickel ions bound to an agarose matrix, the purification of the recombinant protein is achieved knowing that among all the proteins present in the total bacterial extract, only the Lupinus protein binds to the agarose matrix. Subsequently, the Lupinus protein is recovered after an appropriate set of washes and elutions, and the His-mark is removed after treatment with an appropriate proteolytic enzyme. The careful choice of an appropriate promoter is a prerequisite for the genetic modification of plants. In the literature, several types of promoters are described, which allow the expression of the associated genes. To express the gene fragment encoding the protein described in the present invention, the selected promoter can be inductive or constitutive, depending on the type of expression required. The choice of the promoter is also
important to direct the synthesized protein to the selected cell tissue or compartment (post-transcriptional modifications). The transformation of the plant can be achieved using different methodologies such as, transformation of the plant by Agrobacterium, protoplast transformation, transfer of genes to pollen grains, direct injection into reproductive organs or immature embryos, and particle bombardment. Each of these methods has specific advantages and disadvantages. However, all of these have already been used in different types of plants. To transform plants with the gene fragment encoding the Lupinus protein, the selected method is transformation by Agrobacterium (Fraley et al., 1983), using an appropriate expression vector, which contains a coding region for the associated gene of interest to an appropriate marker gene. Plant regeneration, plant development and transfer of the plant to the culture medium from a single protoplast can be achieved by following several methodologies available in the literature. This procedure includes several steps in the selection of transformed cells and the subsequent cultivation of these cells by the usual methods employed in the
development of embryogenic crops. The regenerated plantlets are finally grown in an appropriate culture medium, usually soil. It is also an objective of the present invention any agricultural formulation that includes as the active ingredient the protein according to claims 1 or 2, or a recombinant form of the protein obtained according to claim 9, characterized by being used in the prevention , control and fight against fungi or pathogenic oomycetes or pests caused by insects, or as a growth promoter or fertilizer. Another aspect of the present invention relates to the frequent reduced levels in vegetable proteins of the diets for humans and animals and, in some cases, to the low protein digestibility and to an unbalanced amino acid composition. In fact, crude preparations containing the Lupinus protein possess not only an important globulin (the Lupinus protein, object of the present invention) but also a variety of albumins that are naturally present in the plant material used in the protein extraction. Therefore, these crude preparations of Lupinus protein are particularly rich in proteins and can be used as a protein supplement in animal nutrition
or humans as tofu (after precipitating the globulin with calcium and magnesium) or as ricotta (after precipitating the albumins). The analysis of the amino acid composition of the Lupinus protein and its great susceptibility to all the proteases analyzed (including trypsin, chymotrypsin, subtilisin, proteinase K and pronase) indicates that this protein has a high nutritional value for animals. However, the protein considered in the present invention is a globulin. For this reason, the Lupinus protein is insoluble in water and in diluted saline solutions, but it is easily soluble in solutions of high ionic strength. However, legume globulins are insoluble only when they are in the presence of calcium, magnesium and other alkaline earth cations (Ferreira et al., 1999). These divalent cations, positively charged at neutral pH values, act as electrostatic bridges between negatively charged globulin molecules, promoting or inducing self-aggregation as complexes that are so large that they become insoluble (Ferreira et al., 1999; Ferreira et al., 2003). Tofu, for example, is a curd similar to cheese or cottage cheese that is prepared by adding calcium and magnesium ions to a hot extract of soybeans. Both cations are used routinely in the preparation
of tofu and can be obtained commercially in the form of Nigari®. In this way, a crude preparation of Lupinus protein, containing both globulins and albumins, can be used in the preparation of Lupinus globulin concentrates after their precipitation with calcium and / or magnesium. Figure 7, for example, shows the precipitation pattern of Lupinus protein () as a function of aggregate concentrations of calcium and magnesium. For comparative purposes, the precipitation profile of its precursor protein, β-conglutin (the main reserve protein present in Lupinus seeds, O) is also presented. The albumins that remain in the resulting serum can also be recovered, for example, by thermal precipitation, in a procedure similar to that used in the preparation of ricotta (thermal precipitation of the milk albumins that remain in the serum after the removal of casein during the making of cheese). In this way, preparations containing the Lupinus protein can be used as a protein supplement in the diet of humans or animals. To understand the potential of the present invention, several practical examples are presented. However, these examples are not limiting in the sense that alternative methodologies can be used in the
use of the Lupinus protein as an agent for antifungal and oomycete control, as an insecticide, as a growth promoter, as a fertilizer or as a complement, a protein in the diet of humans or animals.
EXAMPLES Examples 1 and 2 - Effect of sprinkling the Lupinus protein on the surface of vine leaves infected with the fungus Uncnula necator (the causative agent of powdery mildew on grapevine)
The antifungal activity of the Lupinus protein is evaluated after sprinkling the surface of a vine leaf with a solution containing 200 mg of pure protein / ml. As a control, a similar sheet is sprinkled under identical conditions with water. The results obtained are presented in figure 1 and show that the vine leaves remain healthy two months after sprinkling the leaves with the protein, without traces of the presence of the fungus, although the sprinkled leaves are always and permanently in close contact with leaves highly infected Another test is carried out following an identical methodology, but the observations of the surfaces of treated vine leaves are made using a
Metallurgical microscope (Figure 3).
EXAMPLE 3 Effect of Lup ± nus protein on the germination and development of spores of Unc ± nula necator
The spores of the Uncinula fungus are removed from the surface of infected vine leaves and inoculated on agar with 0.6% (w / v) water, which contains 200 mg of pure Lupinus protein per me, or 200 mg of the fraction of total protein from mature grapes (containing PR proteins) per my. The germination of the spores and the development of the germ tubes is followed by optical microscopy using the contrast phase lens system, for 24 and 48 hours. The results obtained, presented in figure 2, show that there is a marked reduction in the presence of the medium containing the Lupinus protein, not only in the number of germinated spores, but also in the length of the germ tubes. This effect is remarkable when compared to the result observed in the presence of PR proteins.
EXAMPLE 4 Effect of Lupinus protein on the germination and development of spores of the Phomops ± s viticulture fungus (the causative agent of excoriation in the vines)
Spores of the fungus Phomopsis vi tícola are inoculated in PDA medium (potato dextrose agar). After 15 minutes, the spores are removed and mixed with a solution containing the Lupinus protein in a final volume of 2.5 ml. These tiny droplets are placed in petri dishes and covered with slides which are subsequently sealed, creating a humid chamber. The development of the spores is followed by observations with an optical microscope. Clear inhibition of spore germination is evident. After 24 hours the hyphae under development undergo lysis.
EXAMPLE 5 Effect of recombinant Lupinus protein on spore germination of the fungus üncinula necator
The recombinant protein of Lupinus, expressed in bacteria, is purified and its antifungal activity is evaluated. These tests are carried out as previously described in examples 2 and 3. The results
obtained, presented in Figure 4, show that the recombinant protein has antifungal properties identical to those observed for the protein extracted from Lupinus plants. After an incubation period of 48 hours in the presence of the recombinant Lupinus protein, destruction of the cell walls of the spore is observed.
EXAMPLE 6 Effect of recombinant Luplnus protein on spore germination of Plasmopara oomycete for viticulture (the causative agent of pubescent downy mildew)
The spores of the Plasmopara oomycete are removed from the surface of infected vine leaves and placed on agar with 0.6% (w / v) water, which contains 200 mg of pure recombinant Lupinus protein per my. The germination of the spore is followed for 48 hours by optical microscope observations. Spore germination on water agar is used as a control. After 24 hours, the cell walls of the spores are destroyed, with the concomitant release of the cellular contents.
EXAMPLE 7 Effect of sprinkling the protein extracted from Lupinus on rose plants
The bio-stimulatory activity of the Lupinus protein is evaluated after sprinkling the leaf surfaces of a rose with a crude extract of Lupinus containing 200 μg of protein / ml. As a control, a rosebush in an identical development stage and incubated under the same environmental conditions is sprinkled with water. The obtained result, photographed three weeks after sprinkling, is presented in figure 5 and shows a superior growth for the plant sprinkled with the Lupinus protein, which is demonstrated by the premature appearance of the first flower buds.
EXAMPLE 8 Effect of sprinkling the protein extracted from Lupinus on nursery watermelon plants
The bio-stimulating activity of the Lupinus protein is evaluated after spraying the foliar surfaces of 6-week-old nursery watermelon plants with a crude extract of Lupinus containing 200 μg of protein / ml. The test is carried out under conditions of
greenhouse and plants are sprinkled with water (control; A); a crude extract of Lupinus containing 100 μg of protein / ml (B); a plant growth promoter commercially available in the market (concentration recommended by the manufacturer) (C); and a crude Lupinus extract containing 200 μg of protein / ml (D). 24 plants are used in each test. The test is followed during the two subsequent weeks and the results obtained are presented in figure 6. The plants sprinkled with the highest concentration of Lupinus protein (200 μg protein / ml; D) show the highest development and growth superior foliar when compared to plants treated with water or with the plant growth promoter commercially available in the market. Sprayed plants with the lowest concentration of Lupinus protein (100 μg protein / ml, B) have a lower level of development but are still higher than that observed for plants sprinkled only with water. The recommended level of application is therefore to spray the plants with a crude preparation of Lupinus protein containing 200 μg of protein / ml.
EXAMPLE 9 Effect of sprinkling the protein extracted from Lupinus on vines infected with üncinula necator (the fungal agent causing powdery mildew, economically the most important vine disease worldwide)
A crude Lupinus extract containing 200 μg of the Lupinus protein is prepared by me. Vines infected with Uncinula neca tor and kept under greenhouse conditions are sprinkled with the extract or with water (control). 24 hours after the application, the sprinkled plants are observed - in relation to the control, the plants sprinkled with the Lupinus protein present a higher vigor and reveal the appearance of new shoots. This situation is maintained for at least a week, after which the plants, previously weakened by the presence of the fungus, are exuberant and with many new leaves without any symptoms of the disease.
EXAMPLE 10 Determination of the optimal concentrations of calcium and magnesium required for the preparation of a Lupinus tofu protein concentrate
The well-balanced amino acid composition of
Lupinus protein, as well as its excellent digestibility (the protein is easily hydrolyzed in its constituent amino acids by the action of the human digestive tract protests) highlight the great nutritional potential of the protein concentrate of Lupinus prepared after precipitating with 5 mM of calcium + magnesium the globulins present in a crude preparation of the Lupinus protein (see figure 7).
References Fraley, RT, Rogers, SG, Horsch, RB, Sanders, PR, Flick, JS, Adams, SP, Bittner, ML, Brand, LA, Fink, CL, Fry, JS, Galluppi, GR, Goldberg, SB, Hoffman , NL I or, S.C. (1983). Expression of bacterial genes in plant cells. Proceedings of the National Academy of Sciences USA, 80, 4801-4807. Ferreira, R.B., Franco, E. and Teixeira, A.R. (1999) . Calcium- and magnesium- dependent aggregation of legume seed storage proteins. Journal of Agricul tural and Food Chemistry, 47, 3009-3015. Ferreira, R.B., Freitas, R.L. and Teixeira, A.R. (2003). Self-aggregation of legume seed storage proteins inside the protein storage vacuoles is electrostatic in nature, rather than lectin-mediated. FEBS Letters, 534, 106-110.
Claims (15)
- NOVELTY OF THE INVENTION Having described the present invention, it is considered a novelty and therefore the content of the following is claimed as property: CLAIMS 1. - A protein extracted from plants of the genus Lupinus, characterized by: (a) The sequence of amino acid residues presented in (B); (B) 5 'RRQRNPYHFS SQRFQTLYKN RNGKIRVLER FDQRTNRLEN LQNYRIVEFQ SKPNTLILPK HSDADYVLVV LNGRA TITIV NPDRRQAYNL EYGDALRIPA GSTSYILNPD DNQKLRVVKL AIPINNPGYF YDFYPSSTKD QQSYFSGFSR NTLEATFNTR YEEIQRIILG NED 3' (b) The sequence of amino acid residues presented in (B), in which one or more amino acid residues they are absent, have been substituted, added or modified, and the protein exhibits antifungal and anti-oomycete activity, plant growth promoter activity and / or maintains its biological properties.
- 2. A protein extracted from plants of the genus Lupinus according to claim 1, characterized in that it is glycosylated, phosphorylated, rented and / or pre-filed.
- 3. A fragment of DNA encoding the protein according to claim 1, characterized by: (a) The nucleotide sequence presented in (A); (A) 5 'CGTAGACAAAGGAACCCTTATCACTTCAGCTCTCAAAGATTCCAAACTCT TTACAAAAATAGGAATGGCAAAATCCGTGTG CTCGAGAGGTTTGAC- CAAAGAACCAATAGACTTGAGAATCTCCAAAACTACCGCATTGTTGAGTTC CAATCAAAACCTAACA CTCTCATTCTCCCTAAACACTCTGATGCTGAC- TACGTCCTCGTTGTACTCAATGGTAGAGCCACAATCACGATAGTAAACCC TGATAGAAGACAAGCATATAACCTTGAGTATGGCGATGCTCTCAGAATCCC AGCTGGCTCAACTTCATATATCCTTAACCCG GATGACAACCAGAAGCTTA- GAGTAGTCAAGCTCGCAATACCCATCAACAATCCTGGCTACTTTTATGATT TCTATCCATCGA GTACTAAAGACCAACAATCCTACTTCAGTG- ACAAAGGATTATTTTAGGGAATGAGGAT GCTTCAGCAGGAACACTTTAGAGGCCACCTTCAATACTCGTTATGAAGAGA T 3' (b) The nucleotide sequence shown in (A), in which one or more nucleotides are absent, have been replaced, added or modified, and encodes a protein with antifungal and anti-oomycete activity, with plant growth promoter activity and / or maintaining its biological properties.
- 4. A recombinant vector characterized in that it contains the DNA fragment in accordance with the claim 3.- A transformed cell characterized in that it is transformed with the recombinant vector according to claim 4. 6. A transformed cell according to claim 5, characterized in that it is obtained from Escherichia coli. 7. A transformed cell according to claim 5, characterized in that it is obtained from a plant, animal or microorganism. 8. A transgenic plant characterized in that it contains a transformed cell according to claim 5 and because it exhibits resistance against pathogenic fungi, Oomycetes or pests caused by insects, which is obtained by regeneration of the aforementioned transformed cell. 9. A method for producing the protein according to claim 1, characterized in that it includes a culture of transformed cells according to claim 5, 6 and 7 and the recovery of the protein with antifungal activity from a cell culture or of a cellular extract. 10. A crude formulation or preparation of the protein, characterized in that it includes as an active ingredient the protein according to the claims 1 or 2, or its recombinant form obtained according to claim 9. 11.- A crude formulation or preparation of the protein according to claim 10, characterized in that it is used in the prevention, control or control against fungi and Oomycetes. , pathogens or not, pests caused by insects, as a promoter of plant growth and fertilizer. 12. The use of the protein according to claim 1 or 2, or its recombinant form obtained according to claim 9, in the preparation of a formulation, characterized in that it is directed to the prevention, control or fight against fungi and Oomycetes, pathogens or not, insects, as a promoter of plant growth and fertilizer. 13. The use of the protein according to claim 1 or 2, or its recombinant form obtained according to claim 9, in the prevention, control or control against fungi and Oomycetes, pathogens or not, pests caused by insects, as a promoter of plant growth and fertilizer, characterized in that a total or partial extract of Lupinus, which contains the protein according to claim 1 or 2, or its recombinant form obtained according to claim 9 is applied to the plant. 14. - The use of the protein according to claim 1 or 2, or its recombinant form obtained according to claim 9, or a crude preparation containing it, characterized in that it is applied as a bio-stimulant or as a growth promoter and plant development, said bio-stimulating activity can be observed particularly after sprinkling the foliage of plants naturally weakened or infected with pathogens that. 15. The use of the protein according to claims 1 or 2, or its recombinant form obtained according to claim 9, or a crude preparation containing it, characterized in that it is applied in the preparation of protein concentrates for human nutrition or animal with high nutritional value, either after the globulin is precipitated with calcium and magnesium salts or with and without physical treatment, such as heating for albumin precipitation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT103322 | 2005-07-21 | ||
PT103511 | 2006-06-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2008000979A true MX2008000979A (en) | 2008-09-02 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2617052C (en) | Protein extracted from plants of the genus lupinus or produced in recombinant form, nucleotide sequence encoding it and its use in animal nutrition, as a plant growth promoter andin the fight against pathogenic fungi | |
CN113164513A (en) | Compositions and methods for treating pathogenic infections in plants | |
JP2001510995A (en) | Antimicrobial protein | |
JP7221746B2 (en) | Functional peptides with antibacterial activity against plant pathogens | |
MX2008000979A (en) | Protein extracted from plants of the genus lupinus or produced in recombinant form, nucleotide sequence encoding it and its usein animal nutrition, as a plant growth promoter and in the fight against pathogenic fungi | |
CZ289646B6 (en) | Antimicrobial proteins, recombinant DNAs encoding thereof, antimicrobial preparation containing thereof and method of fighting fungi or bacteria | |
Åhman et al. | Potato proteins, and other plant proteins, as potential transgenic resistance factors to pollen beetles in oilseed rape | |
KR100417633B1 (en) | Defense-related stellacyanin gene isolated from Capsicum annuum L. cv. Hanbyul and the use of the pepper stellacyanin gene for the detection of plant resistance reactions | |
EP0457898A1 (en) | Proteinase inhibitory agents and methods for their use | |
PT103322A (en) | PROTEIN EXTRACTED FROM LUPINUS GENDER PLANTS, NUCLEOTYDIC SEQUENCE THAT CODES IT AND ITS USE IN COMBATING PATOGENIC FUNGI BY DIRECT APPLICATION, RECOMBINANT OR EXPRESSION IN TRANSGENIC PLANTS | |
JP2000083675A (en) | New protein, gene coding for the protein and their use | |
JP2003250578A (en) | Antifungal polypeptide and antifungal agent containing the same | |
Kumar et al. | Production of Serine Protease Inhibitors from Momordica dioica Cell Cultures | |
JP2004300038A (en) | Method of controlling pathogenic microorganism of crops and growth promoting method by utilizing antibacterial substance of tulip | |
JP2003204794A (en) | Polypeptide composition and its use |